UTI Healthcare Fund - Direct Plan Unrated
(Erstwhile UTI Pharma & Healthcare)

Regular
Direct Plan
Status: Open for subscription | Invest Online

-0.29%

Change from previous, NAV as on Dec 06, 2019

Growth: R 89.6179
Dividend: R 69.2677
NAV of Other Plans

Category:	Equity: Sectoral-Pharma
Assets:	R 393 crore (As on Oct 31, 2019)
Expense:	1.76% (As on Oct 31, 2019)

GET FUND UPDATES FROM VALUE RESEARCH IN YOUR INBOX

SIP Returns

Amount

Frequency

Start Date

End Date

Please wait while we are fetching data...

Choose the best mutual funds
Reach all your financial goals. Subscribe to Mutual Fund Insight now!

Basic Details
Fund House:	UTI Mutual Fund
Launch Date:	Jan 01, 2013
Benchmark:	S&P BSE Healthcare TRI
Riskometer:	High
Risk Grade:	-
Return Grade:	-
Turnover:	51%
Type:	Open-ended

Investment Details
Return since Launch:		9.52%
Minimum Investment (R)		5,000
Minimum Addl Investment (R)		1,000
Minimum SIP Investment (R)		500
Minimum No of Cheques		6
Minimum Withdrawal (R)		-
Minimum Balance (R)		5,000
Exit Load (%)	1% for redemption within 364 days

Performance

	YTD	1-Month	3-Month	1-Year	3-Year	5-Year	10-Year
Fund	1.11	2.63	5.63	3.07	-1.57	0.72	-
S&P BSE Healthcare TRI	-3.39	0.92	3.14	-1.65	-4.59	-1.63	-
Category	3.93	1.40	5.14	5.46	-0.28	2.04	-
Rank within Category	6	1	4	5	3	3	-
Number of funds in category	7	9	9	7	4	3	0

As on Dec 06, 2019

Peer Comparison

Fund	Rating	Launch	1-Year Ret	3-Year Ret	5-Year Ret	Expense Ratio (%)	Assets (Cr)
UTI Healthcare Fund - Direct Plan	Unrated	Jan-2013	3.07	-1.57	0.72	1.76	393
Mirae Asset Healthcare Fund - Direct Plan	Unrated	Jul-2018	8.18	-	-	0.79	358
Nippon India Pharma Fund - Direct Plan	Unrated	Jan-2013	2.50	2.72	4.52	1.36	2,430
SBI Healthcare Opportunities Fund - Direct Plan	Unrated	Jan-2013	0.86	-4.10	0.87	1.33	937
Tata India Pharma & HealthCare Fund - Direct Plan	Unrated	Dec-2015	8.66	1.84	-	1.16	174

Portfolio

Portfolio Aggregates
	Fund	Benchmark*	Category
Average Mkt Cap (Rs Cr)	25,353.58	-	23,291.84
Giant (%)	-	-	2.86
Large (%)	36.57	-	36.39
Mid (%)	53.37	-	51.76
Small (%)	10.06	-	11.53
Tiny (%)	-	-	-

	Value Research Fund Style


Company	Sector	PE	3Y High	3Y Low	% Assets
Sun Pharmaceutical Inds.	Healthcare	23.98	21.71	5.73	12.51
Cipla	Healthcare	21.92	9.99	3.52	9.51
Lupin	Healthcare	109.67	10.84	0.00	8.85
Divi's Laboratories	Healthcare	37.50	9.43	0.00	8.34
Ipca Laboratories	Healthcare	23.32	7.79	2.06	6.00
Dr. Reddy's Lab	Healthcare	17.82	11.34	0.00	5.72
Cadila Healthcare	Healthcare	19.04	9.87	1.26	5.57
Aurobindo Pharma	Healthcare	10.20	10.12	2.36	4.31
Eris Lifesciences	Healthcare	21.82	3.83	0.00	3.52
Sanofi India	Healthcare	40.81	6.60	0.97	3.24

Indicates an increase or decrease or no change in holding since last portfolio

Indicates a new holding since last portfolio

As on Oct 31, 2019

News and Analysis

Fund News: Ritesh Rathod ceases to be the Fund Manager of UTI Healthcare Fund| Jul 18, 2018
Fund News: Name change in Schemes of UTI Mutual Fund| Mar 28, 2018
Fund News: Change in fund managers of Few Schemes of UTI Mutual Fund| Mar 03, 2017
Fund News: Product Labeling of Schemes of UTI Mutual Fund| Jun 19, 2015
Fund News: UTI India Lifestyle Fund reduces exit load period| Apr 06, 2015
Fund News: UTI MNC Fund revised Exit Load| Oct 01, 2014
More news and analysis on this fund

Contact Information

AMC: UTI Asset Management Company Ltd

Address: UTI Tower, 'GN' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051 | Phone: 022- 66786666 / 66786354 / 1800-22-1230 | Fax: 022-26523031

Email: [email protected]

Website: www.utimf.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.

Address: Karvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills, Hyderabad - 500034 | Phone: 040-23312454

Email: [email protected]

Website: www.karvymfs.com

Related Funds	3-Year Return
Nippon India Pharma Fund - Direct Plan	2.72%
Tata India Pharma & HealthCare Fund - Direct Plan	1.84%
SBI Healthcare Opportunities Fund - Direct Plan	-4.10%